临床研究

联合术前MRI和术后病理评估淋巴结转移在直肠癌患者预后预测中的价值

  • 曾志明 ,
  • 朱攀 ,
  • 马德财 ,
  • 邸小慧 ,
  • 李桂婷 ,
  • 邹文彬 ,
  • 潘希敏
展开
  • 中山大学附属第六医院放射诊断科 (广州 510655);广东省结直肠盆底疾病研究重点实验室 (广州 510655);广州市黄埔区中六生物医学创新研究院 (广州 510655 )

收稿日期: 2023-12-25

  网络出版日期: 2024-06-13

基金资助

国家临床重点专科项目;广东省自然科学基金项目(2023A1515011292);广东省消化系统疾病临床研究中心项目(2020B1111170004)

Prognostic value of combined preoperative MRI and postoperative pathological assessment of lymph node metastasis in rectal cancer patients

  • Zhiming ZENG ,
  • Pan ZHU ,
  • Decai MA ,
  • Xiaohui DI ,
  • Guiting LI ,
  • Wenbin ZHOU ,
  • Ximin. PAN
Expand
  • Department of Radiology,the Sixth Affiliated Hospital,Sun Yat?Sen University,Guangzhou 510655,China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases,the Sixth Affiliated Hospital,Sun Yat?sen University,Guangzhou 510655,China; Biomedical Innovation Center,the Sixth Affiliated Hospital,Sun Yat?sen University,Guangzhou 510655,China

Received date: 2023-12-25

  Online published: 2024-06-13

摘要

目的 探究联合术前磁共振成像(MRI)和术后病理评估淋巴结转移预测直肠癌总生存期的价值。 方法 回顾性收集2016年1月至2021年12月2610例在中山大学附属第六医院组织病理学证实为直肠腺癌患者的临床、病理和影像学资料。所有患者均行MRI检查,并根据淋巴结术前MRI( MRI N)和术后病理( P N)评估的转移情况将患者分为3组:MRI N+但 P N-( MRI N+组)、 P N+但 MRI N-( P N+组)和 MRI N+且 P N+( MRI-P N+组)。使用逆概率加权(IPW)校正混杂因素。采用Kaplan-Meier曲线估计总生存率,并用log-rank检验进行组间比较。使用单因素Cox回归模型分析肿瘤特征与总生存期的相关性,采用双向逐步Cox回归模型确定总生存期的独立危险因素。 结果 MRI-P N+组比 P N+组、 MRI N+组具有更高的肿瘤分期、更频繁的神经周围侵犯、更多的远处转移和更高的死亡风险(均P < 0.05)。Kaplan-Meier曲线显示 MRI N+组、 P N+组和 MRI-P N+组的3年生存率分别为90.5%、79.1%和76.4%;5年生存率分别为85.7%、71.5%和59.2%。双向逐步Cox回归分析显示年龄、肿瘤位置、癌胚抗原、糖类抗原19-9、淋巴结送检个数、病理肿瘤分期、脉管内癌栓、神经周围侵犯、远处转移、新辅助治疗和辅助治疗、MRI-病理淋巴结转移是影响直肠癌患者总生存期的独立危险因素(均P < 0.05)。 结论 联合术前MRI和术后病理评估淋巴结转移有助于更准确预测直肠癌患者的总生存期。

本文引用格式

曾志明 , 朱攀 , 马德财 , 邸小慧 , 李桂婷 , 邹文彬 , 潘希敏 . 联合术前MRI和术后病理评估淋巴结转移在直肠癌患者预后预测中的价值[J]. 实用医学杂志, 2024 , 40(11) : 1560 -1567 . DOI: 10.3969/j.issn.1006-5725.2024.11.016

Abstract

Objective To investigate the value of combining preoperative magnetic resonance imaging(MRI) and postoperative pathological assessment of lymph node metastasis in predicting overall survival in rectal cancer patients. Methods This retrospective study collected clinical, pathological and image information of 2610 patients histopathologically confirmed with rectal adenocarcinoma at the Sixth Affiliated Hospital of Sun Yat-sen University between January 2016 and December 2021. All patients underwent MRI scans and were divided into three groups according to lymph node status assessed by preoperative MRI( MRI N) and postoperative pathology( P N): MRI N+ but P N-( MRI N+ group), P N+ but MRI N-( P N+ group), MRI N+ and P N+( MRI-P N+ group). Inverse probability weighting(IPW) was used to adjust for confounding factors. Kaplan-Meier curves were used to estimate overall survival and log-rank tests were used to compare the difference. Univariate Cox regression models were used to analyze the correlation between tumor characteristics and overall survival, and bidirectional stepwise Cox regression models were used to identify independent risk factors for overall survival. Results The MRI-P N+ group showed higher tumor staging, more frequent perineural invasion, more distant metastases, and a higher risk of death compared to the P N+ group and MRI N+ group(all P < 0.05). Kaplan-Meier curves showed that the 3-year survival rates for the MRI N+ group, P N+ group, and MRI-P N+ group were 90.5%, 79.1%, and 76.4%, respectively; the 5-year survival rates were 85.7%, 71.5%, and 59.2%, respectively. Stepwise Cox regression showed that age, tumor location, carcinoembryonic antigen, carbohydrate antigen 19-9, lymph nodes number, pathological tumor stage, lymphovascular invasion, perineural invasion, distant metastasis, neoadjuvant therapy and adjuvant therapy, and MRI-pathology lymph node status were independent risk factors for overall survival in rectal cancer(all P < 0.05). Conclusion Evaluating the lymph node status by combining preoperative MRI and postoperative pathology helps predict overall survival in rectal cancer patients more accurately.

参考文献

1 SIEGEL R L, MILLER K D, WAGLE N S, et al. Cancer statistics, 2023 [J]. Cancer J Clin, 2023, 73(1): 17-48. doi:10.3322/caac.21763
2 刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读 [J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-14.
3 DEKKER E, TANIS P J, VLEUGELS J L A, et al. Colorectal cancer [J]. Lancet, 2019, 394(10207): 1467-1480. doi:10.1016/s0140-6736(19)32319-0
4 KELLER D S, BERHO M, PEREZ R O, et al. The multidisciplinary management of rectal cancer [J]. Nat Rev Gastroenterol Hepatol, 2020, 17(7): 414-429. doi:10.1038/s41575-020-0275-y
5 BI W L, HOSNY A, SCHABATH M B, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications [J]. CA Cancer J Clin, 2019, 69(2): 127-157. doi:10.3322/caac.21552
6 GLYNNE-JONES R, WYRWICZ L, TIRET E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2018, 29(): iv263. doi:10.1093/annonc/mdy161
7 AMIN M B, GREENE F L, EDGE S B, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J]. CA Cancer J Clin, 2017, 67(2): 93-99. doi:10.3322/caac.21388
8 NG S K, LU C T, PAKNESHAN S, et al. Harvest of lymph nodes in colorectal cancer depends on demographic and clinical characteristics of the patients [J]. Int J Colorectal Dis, 2018, 33(1): 19-22. doi:10.1007/s00384-017-2927-0
9 PEEPLES C, SHELLNUT J, WASVARY H, et al. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant? [J]. Dis Colon Rectum, 2010, 53(11): 1517-1523. doi:10.1007/dcr.0b013e3181f20116
10 HORVAT N, CARLOS TAVARES ROCHA C, CLEMENTE OLIVEIRA B, et al. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management [J]. Radiographics, 2019, 39(2): 367-387. doi:10.1148/rg.2019180114
11 彭俊杰, 朱骥, 刘方奇, 等. 中国局部进展期直肠癌诊疗专家共识 [J]. 中国癌症杂志, 2017, 27(1): 41-80.
12 HAAK H E, BEETS G L, PEETERS K, et al. Prevalence of nodal involvement in rectal cancer after chemoradiotherapy [J]. Br J Surg, 2021, 108(10): 1251-1258. doi:10.1093/bjs/znab194
13 NOUGARET S, JHAVERI K, KASSAM Z, et al. Rectal cancer MR staging: pearls and pitfalls at baseline examination [J]. Abdom Radiol(NY), 2019, 44(11): 3536-3548. doi:10.1007/s00261-019-02024-0
14 ZHANG Z, CHEN Y, WEN Z, et al. MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison [J]. Cancer Imaging, 2023, 23(1): 67. doi:10.1186/s40644-023-00589-0
15 唐贤朋, 利锡贵, 肖耀成, 等. 腔内超声及磁共振对局部进展期直肠癌诊断准确性的研究 [J]. 实用医学杂志, 2022, 38(22): 2850-2854. doi:10.3969/j.issn.1006-5725.2022.22.016
16 易呈浩, 葛维挺, 黄彦钦, 等. 1368例结直肠癌TNM分期及预后分析 [J]. 中国肿瘤临床, 2012, 39(9): 597-601. doi:10.3969/j.issn.1000-8179.2012.09.027
17 BRUNNER W, WIDMANN B, MARTI L, et al. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis [J]. Surg Endosc, 2016, 30(10): 4405-4015. doi:10.1007/s00464-016-4759-3
18 GABER C E, EDWARDS J K, LUND J L, et al. Inverse Probability Weighting to Estimate Exposure Effects on the Burden of Recurrent Outcomes in the Presence of Competing Events [J]. Am J Epidemiol, 2023, 192(5): 830-839. doi:10.1093/aje/kwad031
19 KAUR H, ERNST R D, RAUCH G M, et al. Nodal drainage pathways in primary rectal cancer: anatomy of regional and distant nodal spread [J]. Abdom Radiol(NY), 2019, 44(11): 3527-3535. doi:10.1007/s00261-019-02094-0
20 ORANGIO G R, GAGLIARDI G. Corman's Colon and Rectal Surgery, 6th edition [J]. Techniques in Coloproctology, 2013, 17(3). doi:10.1007/s10151-013-0994-y
21 SCHAAP D P, OGURA A, NEDEREND J, et al. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer [J]. Br J Surg, 2018, 105(13): 1844-1852. doi:10.1002/bjs.10949
22 OGURA A, KONISHI T, BEETS G L, et al. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy [J]. JAMA Surg, 2019, 154(9): e192172. doi:10.1001/jamasurg.2019.2172
23 张建锋, 高相鑫, 武雪亮, 等. 结直肠癌NO.253淋巴结转移的危险因素分析 [J]. 实用医学杂志, 2021, 37(22): 2893-7. doi:10.3969/j.issn.1006-5725.2021.22.013
24 LI M, ZHU Y Z, ZHANG Y C, et al. Radiomics of rectal cancer for predicting distant metastasis and overall survival [J]. World J Gastroenterol, 2020, 26(33): 5008-5021. doi:10.3748/wjg.v26.i33.5008
25 AL-SUKHNI E, MILOT L, FRUITMAN M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis [J]. Ann Surg Oncol, 2012, 19(7): 2212-2223. doi:10.1245/s10434-011-2210-5
26 高树全, 武雪亮, 薛军, 等. 中低位局部进展期直肠癌行新辅助放化疗后临床完全缓解患者采取等待观察策略的预后及影响因素分析 [J]. 实用医学杂志, 2022, 38(21): 2691-2696. doi:10.3969/j.issn.1006-5725.2022.21.011
27 唐志良,冯平,郑小明. 直肠癌根治术后局部复发37例临床分析[J]. 热带医学杂志, 2005(2):237-239. doi:10.3969/j.issn.1672-3619.2005.02.044
文章导航

/